The Chamber of Cosmetics Industry of the Philippines, Inc. (CCIP) convened cosmetics and personal care stakeholders for a milestone dialogue with the Food and Drug Administration (FDA) during its 3rd General Membership Meeting (GMM) held at the SMX Convention Center.
With the theme “FDA Frontline: What’s New & What’s Next?”, the event—held in conjunction with the Beauty + Health & Wellness Convention—served as a vital platform for members to raise regulatory concerns, exchange insights, and gain first-hand updates on new FDA policies, digital reforms, and processes shaping the cosmetics and personal care industry.
Distinguished speakers included CCIP President Christine Reyes, Executive Vice President for External Affairs Janina Gutierrez-Tan (JRadiance Corporation), and FDA representatives Esperanza Almenanza (Center for Cosmetics Regulation and Research), Ralph Christofer Manapat (Regulation Officer for Cosmetic and Beauty Products), and Florlita Gabuna.
In her address, Reyes emphasized the importance of open collaboration between regulators and the private sector.
“It’s rare for industry stakeholders to have this level of direct interaction with the FDA. This gathering demonstrates how partnership and dialogue can move the cosmetics industry forward while upholding consumer safety,” she said.
During her presentation on Post-Marketing Surveillance (PMS), Almenanza discussed how the FDA monitors and verifies cosmetic products through consumer complaints, routine sampling, and review of advertisements and marketing claims.
“Brands should not fear receiving a notice of non-compliance. What matters most is transparency and prompt corrective actions. Compliance is a shared responsibility, not a punishment,” she explained, adding that product recall protocols exist to protect consumers based on risk assessment and urgency.
Acknowledging ongoing processing delays, FDA representatives also introduced the Food and Drug Action Center (FDAC) hotline as a dedicated channel for follow-ups, aimed at improving communication and reducing backlogs. The FDA is likewise developing new guidelines for Functional Pop Beauty (F-POP) cosmetics—aligned with ASEAN standards and inspired in part by Korea’s certification model for functional cosmetics.
In addressing customs and importation challenges, FDA clarified that while it has no direct authority over the Bureau of Customs, it remains proactive in issuing advisories to assist importers. CCIP, in turn, reaffirmed its commitment to supporting members affected by overlapping or unclear requirements outside FDA’s jurisdiction.
Through this continued partnership, CCIP strengthens its role as a vital bridge between regulators and the private sector—advocating for compliance as a foundation for innovation, consumer trust, and sustainable growth. This collaboration positions the Philippines as a rising player in the global cosmetics and personal care market.
The CCIP is a non-profit trade association representing over 180 members across the cosmetics value chain, including manufacturers, importers, distributors, suppliers, and service providers. As a founding member of the ASEAN Cosmetics Association, CCIP serves as the unified voice of the Philippine cosmetics industry—promoting regulatory alignment, international collaboration, and global competitiveness.
